315 related articles for article (PubMed ID: 21198257)
41. Current epidemiology of cholangiocarcinoma in Western countries.
Vithayathil M; Khan SA
J Hepatol; 2022 Dec; 77(6):1690-1698. PubMed ID: 35977611
[TBL] [Abstract][Full Text] [Related]
42. Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
Plentz RR; Malek NP
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):245-52. PubMed ID: 25966425
[TBL] [Abstract][Full Text] [Related]
43. Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas.
Kim BH; Cho NY; Choi M; Lee S; Jang JJ; Kang GH
Arch Pathol Lab Med; 2007 Jun; 131(6):923-30. PubMed ID: 17550320
[TBL] [Abstract][Full Text] [Related]
44. Extrahepatic cholangiocarcinoma: current surgical strategy.
Boutros C; Somasundar P; Espat NJ
Surg Oncol Clin N Am; 2009 Apr; 18(2):269-88, viii. PubMed ID: 19306812
[TBL] [Abstract][Full Text] [Related]
45. Intrahepatic, perihilar and distal cholangiocarcinoma: Management and outcomes.
Waseem D; Tushar P
Ann Hepatol; 2017 Jan-Feb 2017; 16(1):133-139. PubMed ID: 28051802
[TBL] [Abstract][Full Text] [Related]
46. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
Tischoff I; Tannapfel A
Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
[TBL] [Abstract][Full Text] [Related]
47. New staging system and a registry for perihilar cholangiocarcinoma.
Deoliveira ML; Schulick RD; Nimura Y; Rosen C; Gores G; Neuhaus P; Clavien PA
Hepatology; 2011 Apr; 53(4):1363-71. PubMed ID: 21480336
[TBL] [Abstract][Full Text] [Related]
48. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
Welzel TM; Graubard BI; El-Serag HB; Shaib YH; Hsing AW; Davila JA; McGlynn KA
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1221-8. PubMed ID: 17689296
[TBL] [Abstract][Full Text] [Related]
49. Anatomical, histomorphological and molecular classification of cholangiocarcinoma.
Kendall T; Verheij J; Gaudio E; Evert M; Guido M; Goeppert B; Carpino G
Liver Int; 2019 May; 39 Suppl 1():7-18. PubMed ID: 30882996
[TBL] [Abstract][Full Text] [Related]
50. Cholangiocarcinoma.
Krasinskas AM
Surg Pathol Clin; 2018 Jun; 11(2):403-429. PubMed ID: 29751883
[TBL] [Abstract][Full Text] [Related]
51. Case series of 17 patients with cholangiocarcinoma among young adult workers of a printing company in Japan.
Kubo S; Nakanuma Y; Takemura S; Sakata C; Urata Y; Nozawa A; Nishioka T; Kinoshita M; Hamano G; Terajima H; Tachiyama G; Matsumura Y; Yamada T; Tanaka H; Nakamori S; Arimoto A; Kawada N; Fujikawa M; Fujishima H; Sugawara Y; Tanaka S; Toyokawa H; Kuwae Y; Ohsawa M; Uehara S; Sato KK; Hayashi T; Endo G
J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):479-88. PubMed ID: 24420816
[TBL] [Abstract][Full Text] [Related]
52. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW
Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
[TBL] [Abstract][Full Text] [Related]
53. Safety and benefits of major hepatectomy with extrahepatic bile duct resection in older perihilar cholangiocarcinoma patients.
Maeda K; Kuriyama N; Ito T; Gyoten K; Hayasaki A; Fujii T; Iizawa Y; Murata Y; Tanemura A; Kishiwada M; Mizuno S
Langenbecks Arch Surg; 2022 Nov; 407(7):2861-2872. PubMed ID: 35996005
[TBL] [Abstract][Full Text] [Related]
54. Neuroendocrine Tumor of the Hilar Bile Duct.
Umezaki N; Hashimoto D; Yamashita YI; Nakagawa S; Nakao Y; Itoyama R; Yusa T; Yamao T; Okabe H; Imai K; Hayashi H; Chikamoto A; Baba H
Anticancer Res; 2019 Feb; 39(2):903-907. PubMed ID: 30711974
[TBL] [Abstract][Full Text] [Related]
55. Phenotypic diversity of intrahepatic and extrahepatic cholangiocarcinoma on aspiration cytology and core needle biopsy: case series and review of the literature.
Chaudhary HB; Bhanot P; Logroño R
Cancer; 2005 Aug; 105(4):220-8. PubMed ID: 15952192
[TBL] [Abstract][Full Text] [Related]
56. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma.
Ahn KS; Kang KJ; Kang YN; Kim YH; Kim TS
BMC Gastroenterol; 2016 Feb; 16():21. PubMed ID: 26911927
[TBL] [Abstract][Full Text] [Related]
57. Cholangiocarcinoma: descriptive epidemiology and risk factors.
de Martel C; Plummer M; Franceschi S
Gastroenterol Clin Biol; 2010 Mar; 34(3):173-80. PubMed ID: 20202771
[TBL] [Abstract][Full Text] [Related]
58. Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma.
Yang B; House MG; Guo M; Herman JG; Clark DP
Mod Pathol; 2005 Mar; 18(3):412-20. PubMed ID: 15467712
[TBL] [Abstract][Full Text] [Related]
59. Descriptive epidemiology of cholangiocarcinoma and clonorchiasis in Korea.
Shin HR; Oh JK; Lim MK; Shin A; Kong HJ; Jung KW; Won YJ; Park S; Park SJ; Hong ST
J Korean Med Sci; 2010 Jul; 25(7):1011-6. PubMed ID: 20592891
[TBL] [Abstract][Full Text] [Related]
60. Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.
Saha SK; Zhu AX; Fuchs CS; Brooks GA
Oncologist; 2016 May; 21(5):594-9. PubMed ID: 27000463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
